PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-11

Date Title Company
11-Sep-2023 LIB Therapeutics Appoints David Cory as Chief Executive Officer as Lead Clinical Programs Achieve Phase 3 Completion Businesswire
11-Sep-2023 Charles River Laboratories to Present at Baird and Morgan Stanley Conferences Businesswire
11-Sep-2023 Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH) Businesswire
11-Sep-2023 Navigating Regulatory Complexity: Global Regulatory Affairs Outsourcing Market on a Growth Trajectory - ResearchAndMarkets.com Businesswire
11-Sep-2023 Sweet Success: Global Xylitol Market Set to Soar on Pharmaceutical and Personal Care Demand - ResearchAndMarkets.com Businesswire
11-Sep-2023 Phase 2 Data Demonstrate Potential of Vergent Biosciences’ Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries Businesswire
11-Sep-2023 Blue Earth Therapeutics Announces Promising Results of Preclinical Evaluation of 225Ac-rhPSMA-10.1 for Potential Targeted Alpha Therapy of Prostate Cancer Businesswire
11-Sep-2023 ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial Businesswire
11-Sep-2023 Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer Businesswire
11-Sep-2023 The Patient Portal Market Set to Reach US$22.29 Billion with a Striking 20% CAGR from 2022 to 2032, | Forecasted by FMI MARKITWIRED
11-Sep-2023 Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Businesswire
11-Sep-2023 Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company Epigenomics AG
11-Sep-2023 Sustainable Surge: Global Plant-Based Excipients Market to Thrive on Rising Demand for Eco-Friendly Pharmaceutical Ingredients - ResearchAndMarkets.com Businesswire
11-Sep-2023 Back Therapy Kits Market’s Impressive 4.6% CAGR Propels it to US$ 5.8 Million by 2032 | According to FMI Experts MARKITWIRED
11-Sep-2023 Neurovascular Devices Market Soars at 8.5% CAGR to Reach US$6.2 Billion by 2032 | FMI Analysis MARKITWIRED
11-Sep-2023 Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis Businesswire
11-Sep-2023 Global Healthcare Cold Chain Logistics Market Outlook & Forecasts Report 2023-2028: Technology Advancements Driving Competition - Blockchain Integration Elevating Industry Growth - ResearchAndMarkets.com Businesswire
11-Sep-2023 Dental Fluorescence Analyzer Market Envisioned at US$ 725 Million by 2032, Backed by a Strong 9% CAGR | FMI Report MARKITWIRED
11-Sep-2023 The Peripheral Micro Catheters Market’s Trajectory to US$ 1872 Million by 2032, at a 7.5% CAGR | FMI Insights MARKITWIRED
11-Sep-2023 Patient Transport Services Market to Witness Exponential Growth at 12% CAGR, Surpassing US$117.1 Billion by 2032 | Says FMI MARKITWIRED